|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| License | |||||
| Product Sales and Royalties | |||||
| Total net revenues | |||||
| Cost of sales | |||||
| Cost of sales | |||||
| License | |||||
| Product Sales and Royalties | |||||
| Total cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest and other (expense) income, net | |||||
| Gain on PPP loan forgiveness | |||||
| Gain on equipment sale | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Net loss per share, basic and diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding, basic and diluted (in shares) | |||||
Loading...